Mohammed Al‐Nazawi

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Mahmoud Kandeel, Mohammed Al‐Nazawi · Life Sciences · 2020 · 429 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +11

From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes

Mahmoud Kandeel, Abdelazim Ibrahim, Mahmoud Fayez et al. · Journal of Medical Virology · 2020 · 196 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design

Abdullah Sheikh, Abdulla Al‐Taher, Mohammed Al‐Nazawi et al. · Journal of Virological Methods · 2020 · 80 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus

Mahmoud Kandeel, Abdulla Al‐Taher, Byoung Kwon Park et al. · Journal of Medical Virology · 2020 · 56 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers

Mahmoud Kandeel, Mizuki Yamamoto, Abdulla Al‐Taher et al. · Biomolecules & Therapeutics · 2020 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13